Clinical Trial

Postoperative Anti-infective Strategy Following Pancreaticoduodenectomy in Patients With Preoperative Biliary Stent

Study acronym: FRENCH24 ANIS
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main objective of the study is to compare 2 broad-spectrum antibiotic (Piperacillin / Tazobactam) treatment modalities, following pancreaticoduodenectomy in patients with preoperative biliary stent, to demonstrate the superiority of a 5-day post-operative antibiotic therapy to antibiotic prophylaxis on the occurrence of surgical site infections (SSI)
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-07 -> 2028-09 2026-06-10
minor Completion pushed: 2028-07 -> 2028-09 2026-06-10
Trial Details
NCT Number NCT06123169
Lead Sponsor University Hospital, Rouen
Conditions Pancreaticoduodenectomy, Antibiotherapy
Enrollment 326 participants
Start Date 2026-07
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-09